Supha Pharmachem Ltd (SUPHA) quarterly results

AI summary: Results press release, Q2 FY26

Results press release of 17 Nov 2025, summarised by AI from the filing.

No forward guidance was given in the release.

Key takeaways

1. Guidance No forward guidance was given in the release.
2. Change Board reinforced with appointment of Mr. Rambhajan Vishwakarma and Mr. Vignesh Laxman Gawde.
3. Driver Operational discipline and business expansion drove consolidated performance.
4. Risk No risks were acknowledged in the release.

Supha Pharmachem Ltd results press release summary

Original filing on BSE

Supha Pharmachem Ltd earnings call, investor presentation and press release summaries

• Q2 FY26: Results press release (17 Nov 2025)